Impact of 68Ga-DOTATOC PET/MRI on robotic radiosurgery treatment planning in meningioma patients: first experiences in a single institution.

68Ga-DOTATOC = gallium-68–labeled [DOTA0-Phe1-Tyr3]octreotide 68Ga-DOTATOC PET/MRI CyberKnife FSRT = fractionated stereotactic radiation therapy GTV = gross tumor volume IMRT = intensity-modulated radiotherapy IQR = interquartile range MP-RAGE = magnetization-prepared rapid acquisition with gradient echo OAR = organ at risk PET = positron emission tomography PTV = planning target volume RS = radiosurgeon SRS = stereotactic radiosurgery SSTR = somatostatin receptor meningioma stereotactic radiosurgery

Journal

Neurosurgical focus
ISSN: 1092-0684
Titre abrégé: Neurosurg Focus
Pays: United States
ID NLM: 100896471

Informations de publication

Date de publication:
01 06 2019
Historique:
received: 22 01 2019
accepted: 21 03 2019
entrez: 2 6 2019
pubmed: 4 6 2019
medline: 28 8 2020
Statut: ppublish

Résumé

OBJECTIVEFor stereotactic radiosurgery (SRS) planning, precise contouring of tumor boundaries and organs at risk is of utmost importance. Correct interpretation of standard neuroimaging (i.e., CT and MRI) can be challenging after previous surgeries or in cases of skull base lesions with complex shapes. The aim of this study was to evaluate the impact of 68Ga-DOTATOC PET/MRI on treatment planning for image-guided SRS by CyberKnife.METHODSThe authors retrospectively identified 11 meningioma treatments in 10 patients who received a 68Ga-DOTATOC PET/MRI prior to SRS. The planning target volume (PTV) used for the patients' treatment was defined as the reference standard. This was contoured by a treating radiosurgeon (RS0) using fused planning CT and PET/MRI data sets. The same tumors were then contoured by another experienced radiosurgeon (RS1) and by a less-experienced radiosurgeon (RS2), both blinded to PET data sets. A comparison of target volumes with focus on volume-based metrics and distance to critical structures was performed. RS1 and RS2 also filled in a questionnaire analyzing the confidence level and the subjective need for the implementation of PET data sets for contouring.RESULTSAnalysis showed a subjective personal preference for PET/MRI in all cases for both radiosurgeons, particularly in proximity to critical structures. The analysis of the planning volumes per physician showed significantly smaller RS2-PTV in comparison to RS1-PTV and to RS0-PTV, whereas the median volumes were comparable between RS1-PTV and RS2-PTV (median: RS0: 4.3 cm3 [IQR 3.4-6.5 cm3] and RS1: 4.5 cm3 [IQR 2.7-6 cm3] vs RS2: 2.6 cm3 [IQR 2-5 cm3]; p = 0.003). This was also reflected in the best spatial congruency between the 2 experienced physicians (RS0 and RS1). The percentage of the left-out volume contoured by RS1 and RS2 compared to RS0 with PET/MRI demonstrated a relevant left-out-volume portion in both cases with greater extent for the less-experienced radiosurgeon (RS2) (RS1: 19.1% [IQR 8.5%-22%] vs RS2: 40.2% [IQR 34.2%-53%]). No significant differences were detected regarding investigated critical structures.CONCLUSIONSThis study demonstrated a relevant impact of PET/MRI on target volume delineation of meningiomas. The extent was highly dependent on the experience of the treating physician. This preliminary study supports the relevance of 68Ga-DOTATOC PET/MRI as a tool for radiosurgical treatment planning of meningiomas.

Identifiants

pubmed: 31153151
doi: 10.3171/2019.3.FOCUS1925
pii: 2019.3.FOCUS1925
doi:
pii:

Substances chimiques

Ga(III)-DOTATOC 0
Gallium Radioisotopes 0
Organometallic Compounds 0
Radiopharmaceuticals 0
Gallium-68 98B30EPP5S
Octreotide RWM8CCW8GP

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

E9

Auteurs

Güliz Acker (G)

1Department of Neurosurgery and Center for Stroke Research Berlin (CSB).
2Berlin Institute of Health (BIH), Berlin, Germany; and.
3Charité CyberKnife Center.

Anne Kluge (A)

3Charité CyberKnife Center.
4Department of Radiation Oncology, and.

Mathias Lukas (M)

5Department of Nuclear Medicine, Charité-Universitätsmedizin Berlin, Germany.

Alfredo Conti (A)

1Department of Neurosurgery and Center for Stroke Research Berlin (CSB).
3Charité CyberKnife Center.
6Department of Neurosurgery, University of Messina, Messina, Italy.

Diana Pasemann (D)

3Charité CyberKnife Center.
4Department of Radiation Oncology, and.

Franziska Meinert (F)

1Department of Neurosurgery and Center for Stroke Research Berlin (CSB).
3Charité CyberKnife Center.

Phuong Thuy Anh Nguyen (PT)

1Department of Neurosurgery and Center for Stroke Research Berlin (CSB).
3Charité CyberKnife Center.

Claudius Jelgersma (C)

1Department of Neurosurgery and Center for Stroke Research Berlin (CSB).
3Charité CyberKnife Center.

Franziska Loebel (F)

1Department of Neurosurgery and Center for Stroke Research Berlin (CSB).
3Charité CyberKnife Center.

Volker Budach (V)

3Charité CyberKnife Center.
4Department of Radiation Oncology, and.

Peter Vajkoczy (P)

1Department of Neurosurgery and Center for Stroke Research Berlin (CSB).
3Charité CyberKnife Center.

Christian Furth (C)

5Department of Nuclear Medicine, Charité-Universitätsmedizin Berlin, Germany.

Alexander D J Baur (ADJ)

5Department of Nuclear Medicine, Charité-Universitätsmedizin Berlin, Germany.

Carolin Senger (C)

3Charité CyberKnife Center.
4Department of Radiation Oncology, and.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH